ReviewResearch (Washington, D.C.)2026

Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies.

Ziyue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.